These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. Hideyama T; Momose T; Shimizu J; Tsuji S; Kwak S Arch Neurol; 2006 Dec; 63(12):1719-22. PubMed ID: 17172610 [TBL] [Abstract][Full Text] [Related]
24. [Reappraisal of amyotrophic lateral sclerosis with dementia]. Murakami N; Yoshida M Rinsho Shinkeigaku; 1995 Dec; 35(12):1560-2. PubMed ID: 8752463 [TBL] [Abstract][Full Text] [Related]
30. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708 [TBL] [Abstract][Full Text] [Related]
31. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320 [TBL] [Abstract][Full Text] [Related]
32. Multimodal structural MRI in the diagnosis of motor neuron diseases. Ferraro PM; Agosta F; Riva N; Copetti M; Spinelli EG; Falzone Y; Sorarù G; Comi G; Chiò A; Filippi M Neuroimage Clin; 2017; 16():240-247. PubMed ID: 28794983 [TBL] [Abstract][Full Text] [Related]
33. Muscle ultrasonography: a diagnostic tool for amyotrophic lateral sclerosis. Arts IM; Overeem S; Pillen S; Kleine BU; Boekestein WA; Zwarts MJ; Jurgen Schelhaas H Clin Neurophysiol; 2012 Aug; 123(8):1662-7. PubMed ID: 22244867 [TBL] [Abstract][Full Text] [Related]
34. Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. Vázquez-Costa JF; Arlandis S; Hervas D; Martínez-Cuenca E; Cardona F; Pérez-Tur J; Broseta E; Sevilla T J Neurol Sci; 2017 Jul; 378():130-136. PubMed ID: 28566149 [TBL] [Abstract][Full Text] [Related]
35. Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. Mabuchi N; Watanabe H; Atsuta N; Hirayama M; Ito H; Fukatsu H; Kato T; Ito K; Sobue G J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1768-71. PubMed ID: 15548503 [TBL] [Abstract][Full Text] [Related]
36. Demographics and clinical characteristics of primary lateral sclerosis: case series and a review of literature. Ramanathan RS; Rana S Neurodegener Dis Manag; 2018 Feb; 8(1):17-23. PubMed ID: 29316850 [TBL] [Abstract][Full Text] [Related]
37. New findings in facial-onset sensory and motor neuronopathy (FOSMN) syndrome. Pinto WBVR; Naylor FGM; Chieia MAT; de Souza PVS; Oliveira ASB Rev Neurol (Paris); 2019 Apr; 175(4):238-246. PubMed ID: 30293881 [TBL] [Abstract][Full Text] [Related]
38. [Primary lateral sclerosis and lung adenocarcinoma]. Martinez L; Lamaze R; Clément-Duchêne C Rev Mal Respir; 2013 Mar; 30(3):227-30. PubMed ID: 23497933 [TBL] [Abstract][Full Text] [Related]